je.st
news
Tag: valeant
Valeant Pharma says may buy back up to $2 billion worth of securities
2014-11-21 03:33:09| Biotech - Topix.net
The company said it could buy back senior notes, shares or other securities under the new program, which will begin on Nov. 21, the same day its old program ends. The announcement comes a few days after acquisition-hungry Valeant's $54 billion offer to buy Botox maker Allergan Inc "Valeant's board of directors believes that the proposed purchases are in the best interests of the company and are a desirable use of corporate funds," the company said in a statement on Thursday.
Allergan near buyout of up to $65 billion to escape Valeant, Ackman: source
2014-11-17 03:24:15| Biotech - Topix.net
Allergan Inc is close to a buyout deal worth up to $65.5 billion by Actavis Plc, one that could end months of pursuit by Canada's Valeant Pharmaceuticals and William Ackman's hedge fund, Pershing Square Capital Management, according to a person familiar with the matter. Actavis may pay Allergan between $215 and $220 per share, with the final price likely coming at the high end of that range, according to the source.
Tags: source
escape
billion
buyout
Valeant, Allergan Fight for Doctors
2014-11-13 06:36:39| Biotech - Topix.net
As it fights to buy Botox maker Allergan Inc., Valeant Pharmaceuticals International Inc. is investing cash and time wooing the doctors it would need on its side after a takeover. A centerpiece of the effort: Valeant said it met with a total of 45 influential cosmetic surgeons and dermatologists in September at events in Aspen, Colo., and Palm Beach, Fla.
Tags: fight
doctors
allergan
valeant
Valeant: We'll bump Allergan offer to $200 a...
2014-10-27 14:20:38| Biotech - Topix.net
Canadian drugmaker Valeant Pharmaceuticals International Inc. says it will raise its offer for Botox maker Allergan Inc. to $200 or more per share. Valeant made the statement in a letter to Allergan's board released publicly seeking to urge Allergan to talk about an acquisition.
Tags: offer
bump
allergan
valeant
Pershing Square says Allergan CEO led smear campaign against Valeant
2014-10-22 11:21:16| Biotech - Topix.net
Pershing Square Capital Management says that it has uncovered evidence that the management of Allergan Inc. made false and misleading statements about Valeant Pharmaceuticals Inc. as part of a "scorched earth" campaign to thwart the Canadian company's hostile takeover of the California-based maker of Botox. Pershing Square, which is Allergan's largest shareholder and Valeant's ally in the takeover battle, says in a 44-page court filing - which has many portions blacked out and which hasn't been tested in court - that Allergan chief executive David Pyott, who is also chairman of Allergan's board, "personally led the charge and directed much of the misconduct."
Sites : [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] next »